Stay updated on Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    1%
    Check dated 2025-05-08T14:01:15.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    1%
    Check dated 2025-05-01T06:26:54.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2025-04-24T01:21:28.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new version of the study, with the addition of a new collaborator, Aadi Bioscience, Inc., and a new revision number, v2.15.0. Additionally, some detailed descriptions of the study objectives and eligibility criteria have been removed.
    Difference
    45%
    Check dated 2025-04-16T20:39:51.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 17, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.
    Difference
    1%
    Check dated 2025-04-09T16:00:07.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to include information on Ewing Sarcoma while removing references to Lymphosarcoma, indicating a shift in focus towards Ewing Sarcoma. Additionally, the revision number has been updated from v2.14.2 to v2.14.3.
    Difference
    1%
    Check dated 2025-04-02T00:36:35.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.